Publication | Closed Access

N-Methyl-2-[4-(2-methylpropyl)phenyl]-3-(3-methoxy-5-methylpyrazin-2-ylsulfamoyl)benzamide; one of a class of novel benzenesulphonamides which are orally-active, ETA-selective endothelin antagonists

Eta-selective Endothelin AntagonistsMedicinal ChemistryMedicineMechanism Of ActionPharmacological AgentNovel BenzenesulphonamidesPharmacotherapyPharmacologyPharmaceutical ChemistryDrug Discovery